HIGHLIGHTS
- who: Sarah M. AL-Qabbaa et al. from the PharmDProgram, College of Pharmacy, King Saud University, Riyadh, Saudi Arabia have published the research: Sitagliptin Mitigates Diabetic Nephropathy in a Rat Model of Streptozotocin-Induced Type 2 Diabetes: Possible Role of PTP1B/JAK-STAT Pathway, in the Journal: (JOURNAL)
- what: This study examined the therapeutic effects of a dipeptidyl peptidase inhibitor on DN and explored the underlying mechanism. The authors investigated the therapeutic potential of sitagliptin in DN and the possible related signaling pathways, particularly inflammation, to understand this. The findings of this study demonstrated that . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.